Influence of the CYP2D6*10 allele on the metabolism of mexiletine by human liver microsomes

Br J Clin Pharmacol. 2001 Jul;52(1):100-3. doi: 10.1046/j.0306-5251.2001.01411.x.

Abstract

Aims: To study the influence of CYP2D6*10 on the formation of p-hydroxymexiletine (PHM) and hydroxymethylmexiletine (HMM) using microsomes from human liver of known genotypes.

Methods: Microsomes from human livers of genotype CYP2D6*1/*1 (n = 5), *1/*10 (n = 6) and *10/*10 (n = 6) were used in this study. The formation of PHM and HMM was determined by high-performance liquid chromatography.

Results: The formation rates of PHM and HMM were decreased by more than 50% and 85% in CYP2D6*1/*10 and *10/*10 microsomes, respectively, compared with *1/*1 microsomes.

Conclusions: The metabolism of mexiletine to form PHM and HMM appears to be impaired to a significant extent in human liver microsomes from hetero- and homozygotes of CYP2D6*10.

MeSH terms

  • Alleles
  • Anti-Arrhythmia Agents / pharmacokinetics*
  • Chromatography, High Pressure Liquid
  • Cytochrome P-450 CYP2D6 / genetics*
  • Heterozygote
  • Homozygote
  • Humans
  • Hydroxylation
  • Mexiletine / pharmacokinetics*
  • Microsomes, Liver / metabolism*
  • Polymerase Chain Reaction
  • Polymorphism, Restriction Fragment Length

Substances

  • Anti-Arrhythmia Agents
  • Mexiletine
  • Cytochrome P-450 CYP2D6